- Home
- SILO vs SPRC Comparison
SILO vs SPRC Comparison
Compare SILO & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- SPRC
- Stock Information
- Founded
- SILO 2010
- SPRC 2004
- Country
- SILO United States
- SPRC Israel
- Employees
- SILO N/A
- SPRC N/A
- Industry
- SILO Apparel
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- SPRC Health Care
- Exchange
- SILO Nasdaq
- SPRC Nasdaq
- Market Cap
- SILO 3.1M
- SPRC 3.4M
- IPO Year
- SILO N/A
- SPRC N/A
- Fundamental
- Price
- SILO $0.58
- SPRC $0.31
- Analyst Decision
- SILO
- SPRC
- Analyst Count
- SILO 0
- SPRC 0
- Target Price
- SILO N/A
- SPRC N/A
- AVG Volume (30 Days)
- SILO 2.4M
- SPRC 302.0K
- Earning Date
- SILO 05-09-2025
- SPRC 02-15-2025
- Dividend Yield
- SILO N/A
- SPRC N/A
- EPS Growth
- SILO N/A
- SPRC N/A
- EPS
- SILO N/A
- SPRC N/A
- Revenue
- SILO $72,102.00
- SPRC $1,306,000.00
- Revenue This Year
- SILO $1.86
- SPRC N/A
- Revenue Next Year
- SILO N/A
- SPRC N/A
- P/E Ratio
- SILO N/A
- SPRC N/A
- Revenue Growth
- SILO N/A
- SPRC N/A
- 52 Week Low
- SILO $0.41
- SPRC $0.20
- 52 Week High
- SILO $4.50
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- SILO 45.16
- SPRC 50.15
- Support Level
- SILO $0.43
- SPRC $0.30
- Resistance Level
- SILO $0.49
- SPRC $0.33
- Average True Range (ATR)
- SILO 0.06
- SPRC 0.02
- MACD
- SILO 0.03
- SPRC -0.00
- Stochastic Oscillator
- SILO 45.03
- SPRC 58.82
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.